Federal regulators say Teva Pharmaceuticals Industries will pay $1.2 billion to settle charges that one of its subsidiaries illegally blocked the launch of generic versions of the blockbuster sleeping pill Provigil.
Associated Press, Los Angeles Times: Business
Thu, 05/28/2015 - 8:31am